208 related articles for article (PubMed ID: 28176349)
21. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
22. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
[TBL] [Abstract][Full Text] [Related]
23. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
[TBL] [Abstract][Full Text] [Related]
24. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis.
Molinari M; Helton S
Am J Surg; 2009 Sep; 198(3):396-406. PubMed ID: 19520354
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
[TBL] [Abstract][Full Text] [Related]
26. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.
Lim C; Compagnon P; Sebagh M; Salloum C; Calderaro J; Luciani A; Pascal G; Laurent A; Levesque E; Maggi U; Feray C; Cherqui D; Castaing D; Azoulay D
HPB (Oxford); 2015 Jul; 17(7):611-23. PubMed ID: 25980326
[TBL] [Abstract][Full Text] [Related]
27. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada.
Muszbek N; Shah S; Carroll S; McDonald H; Dale P; Maroun J; Knox J
Curr Med Res Opin; 2008 Dec; 24(12):3559-69. PubMed ID: 19032137
[TBL] [Abstract][Full Text] [Related]
29. Comparative cost-effectiveness of cabozantinib as second-line therapy for patients with advanced hepatocellular carcinoma in Germany and the United States.
Sieg M; Hartmann M; Settmacher U; Arefian H
BMC Gastroenterol; 2020 Apr; 20(1):120. PubMed ID: 32316925
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
Ladabaum U; Cheng SL; Yao FY; Roberts JP
Clin Transplant; 2011; 25(2):283-91. PubMed ID: 20156221
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
[TBL] [Abstract][Full Text] [Related]
33. Economic evaluation of sorafenib in unresectable hepatocellular carcinoma.
Carr BI; Carroll S; Muszbek N; Gondek K
J Gastroenterol Hepatol; 2010 Nov; 25(11):1739-46. PubMed ID: 21039835
[TBL] [Abstract][Full Text] [Related]
34. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective.
Sarasin FP; Giostra E; Mentha G; Hadengue A
Hepatology; 1998 Aug; 28(2):436-42. PubMed ID: 9696009
[TBL] [Abstract][Full Text] [Related]
35. Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians.
Likhitsup A; Parikh ND
Pharmacoeconomics; 2020 Jan; 38(1):5-24. PubMed ID: 31573053
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis.
Gournay J; Tchuenbou J; Richou C; Masliah C; Lerat F; Dupas B; Martin T; Nouel JF; Schnée M; Montigny P; D'Alincourt A; Hamy A; Paineau J; Le Néel JC; Le Borgne J; Galmiche JP
Aliment Pharmacol Ther; 2002 Aug; 16(8):1529-38. PubMed ID: 12182753
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
[TBL] [Abstract][Full Text] [Related]
38. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
39. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience.
Zhang T; Zeng Y; Huang J; Liao M; Wu H
J Surg Res; 2014 Oct; 191(2):370-8. PubMed ID: 24766727
[TBL] [Abstract][Full Text] [Related]
40. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis.
Cho YK; Kim JK; Kim WT; Chung JW
Hepatology; 2010 Apr; 51(4):1284-90. PubMed ID: 20099299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
